| Financial Year |
March 31 2023 |
| Monetary Funds |
736,436,828.16 |
| Held-for-trading Financial Assets |
107,045,838.83 |
| Notes Receivable |
-- |
| Accounts Receivable |
325,455,970.91 |
| Advances to Suppliers |
47,466,511.24 |
| Other Receivables |
8,219,476.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
382,678,941.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
235,672.01 |
| Other Current Assets |
27,703,902.98 |
| Total Current Assets |
1,652,413,558.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
277,562,511.07 |
| Investment Properties |
-- |
| Fixed Assetes |
1,186,223,674.79 |
| Under-construction Projects |
95,876,565.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
200,064,820.65 |
| R&D expenses |
-- |
| Goodwill |
406,455,276.33 |
| Long-Term Deferred and Prepaid Expenses |
22,450,986.90 |
| Deferred Income Tax Assets |
111,921,847.40 |
| Other Non-Current Assets |
199,868,020.31 |
| Sub-Total of Non-Current Assets |
2,876,324,868.56 |
| Total Assets |
4,528,738,427.47 |
| Short-Term Loans |
37,012,936.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
170,985,195.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
71,971,675.83 |
| Taxes Payable |
33,299,800.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
163,618,736.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,525,120.63 |
| Other Current Liabilities |
21,230,718.68 |
| Sub-Total of Current Liabilities |
661,930,950.65 |
| Long-term Loans |
51,308,693.42 |
| Bonds Payable |
418,564,371.60 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,016,759.92 |
| Deferred Income Tax Liabilities |
29,736,751.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
643,386,791.46 |
| Total Liabilities |
1,305,317,742.11 |
| Paid-In Capital(Or Share Stock) |
564,265,373.00 |
| Capital Surplus |
1,255,681,109.43 |
| Surplus Reserve |
383,564,539.76 |
| LESS:Treasury Stock |
168,585,184.23 |
| Undistributed Profits |
913,179,596.98 |
| Minority Stockholder's Interest |
39,413,083.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,184,007,602.24 |
| Owner's Equity（Stockholder's Equity） |
3,223,420,685.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,528,738,427.47 |
